Isthmus Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.37M | Buy |
45,197
+2,732
| +6% | +$204K | 0.39% | 71 |
|
|
2025
Q1 | $2.7M | Buy |
42,465
+2,245
| +6% | +$143K | 0.34% | 74 |
|
|
2024
Q4 | $3.14M | Buy |
40,220
+450
| +1% | +$35.1K | 0.38% | 70 |
|
|
2024
Q3 | $3.2M | Sell |
39,770
-8,326
| -17% | -$669K | 0.38% | 68 |
|
|
2024
Q2 | $3.98M | Buy |
48,096
+58
| +0.1% | +$4.8K | 0.47% | 61 |
|
|
2024
Q1 | $4.1M | Buy |
48,038
+30,150
| +169% | +$2.57M | 0.47% | 61 |
|
|
2023
Q4 | $1.53M | Buy |
+17,888
| New | +$1.53M | 0.2% | 102 |
|
|
2016
Q1 | – | Sell |
-13,300
| Closed | -$429K | – | 247 |
|
|
2015
Q4 | $429K | Buy |
13,300
+1,056
| +9% | +$34.1K | 0.15% | 108 |
|
|
2015
Q3 | $396K | Buy |
12,244
+305
| +3% | +$9.86K | 0.15% | 103 |
|
|
2015
Q2 | $494K | Buy |
11,939
+634
| +6% | +$26.2K | 0.16% | 100 |
|
|
2015
Q1 | $508K | Buy |
11,305
+446
| +4% | +$20K | 0.17% | 89 |
|
|
2014
Q4 | $406K | Buy |
+10,859
| New | +$406K | 0.14% | 105 |
|